Sublime

Meet Biograph. The world’s most advanced preventive health & diagnostics clinic designed to drive meaningful advances in #healthspan & #lifespan. Our best in class evaluation has helped 15%+ of members discover urgent or life-altering insights. Read more: https://t.co/6E2sS03AQd https://t.co/NW16t3TXlm

Introducing OpenBioLLM-Llama3-70B & 8B: The most capable openly available Medical-domain LLMs to date! 🩺💊🧬 Outperforms industry giants like GPT-4, Gemini, Meditron-70B, Med-PaLM-1, and Med-PaLM-2 in the biomedical domain. 🏥📈 🌟 OpenBioLLM-70B delivers SOTA performance, setting a new... See more

AI told me the diseases I was at risk of based on modern medical research from my raw genome sequence. Genealogy companies don't provide this data because of FDA regulation risk. o3 went through ~15MB of raw data in 4mins. A country of geniuses in a... See more

A new position in David Poppe’s Giverny Capital - Medpace Holdings, providing clinical trial tests for small biotech companies. The founder owns 17%, stock at 25x PE. $MEDP The link to the full Q3 letter in reply. https://t.co/5ktdHceiDS

🧬 Biopharma 𝕏 Weekly Recap 📝 Interesting posts/ppl to check out! 👇 🚨 @yaireinhorn Biotech sector shrinks as public biotech companies drop 15% since 2022 📉 » https://t.co/G11bvicBe5 🔬 @GeneInvesting Side-by-side... See more